Protocol Description

This study is seeking to evaluate the impact that hormonal birth control methods have on immune response and HIV risk.

Eligibility Criteria

  • Female adolescents ages 18-19 OR 25-45 who are using Mirena, Skyla, Nexplanon/Implanon (the implant), or a non-hormonal method of birth control.
  • HIV negative and not pregnant 
  • Willing to have genital samples collected


  • One study visit, where the researchers will do a genital sample collection.

Status: Open to enrollment

Additional Information

  • Participants will receive $140

Primary Investigator

Katherine Bunge, MD

Contact Information

  • Call 412-641-4242